Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study
Year: 2020
Type: review
Study design: Observational Study
Abstract: BACKGROUND: The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users. METHODS: The Allergy Diary-MASK-air-mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis. RESULTS: 9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines. CONCLUSIONS: This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year.
Authors: the MASK study group, A. Bédard, X. Basagaña, J. M. Anto, J. Garcia-Aymerich, P. Devillier, S. Arnavielhe, A. Bedbrook, G. L. Onorato, W. Czarlewski, R. Murray, R. Almeida, J. A. Fonseca, J. Correia da Sousa, E. Costa, M. Morais-Almeida, A. Todo-Bom, L. Cecchi, G. De Feo, M. Illario, E. Menditto, R. Monti, C. Stellato, M. T. Ventura, I. Annesi-Maesano, I. Bosse, J. F. Fontaine, N. Pham-Thi, M. Thibaudon, P. Schmid-Grendelmeier, F. Spertini, N. H. Chavannes, W. J. Fokkens, S. Reitsma, R. Dubakiene, R. Emuzyte, V. Kvedariene, A. Valiulis, P. Kuna, B. Samolinski, L. Klimek, R. Mösges, O. Pfaar, S. Shamai, R. E. Roller-Wirnsberger, P. V. Tomazic, D. Ryan, A. Sheikh, T. Haahtela, S. Toppila-Salmi, E. Valovirta, V. Cardona, J. Mullol, A. Valero, M. Makris, N. G. Papadopoulos, E. P. Prokopakis, F. Psarros, C. Bachert, P. W. Hellings, B. Pugin, C. Bindslev-Jensen, E. Eller, I. Kull, E. Melén, M. Wickman, G. De Vries, M. van Eerd, I. Agache, I. J. Ansotegui, S. Bosnic-Anticevich, A. A. Cruz, T. Casale, J. C. Ivancevich, D. E. Larenas-Linnemann, M. Sofiev, D. Wallace, S. Waserman, A. Yorgancioglu, D. Laune, J. Bousquet
Institutions: Universitat Pompeu Fabra, Barcelona Institute for Global Health, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, Municipal Institute for Medical Research, Hospital del Mar Research Institute, Université Paris-Saclay, Hôpital Foch, Centre Hospitalier Universitaire de Montpellier, University of Cambridge, Universidade do Porto, University of Minho, Hospital CUF Descobertas, Unidade Local de Saúde de Coimbra, University of Coimbra, Azienda Usl Toscana Centro, University of Salerno, Federico II University Hospital, University of Naples Federico II, University of Turin, University of Bari Aldo Moro, Inserm, Sorbonne Université, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, École Polytechnique, Réseau National de Surveillance Aérobiologique, University Hospital Zurich, Centre Hospitalier Universitaire Vaudois, Leiden University Medical Center, Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Vilnius University, European Union of Medical Specialists, Medical University of Lodz, Medical University of Warsaw, Zentrum für Rhinologie und Allergologie, University of Cologne, Philipps University of Marburg, Medical University of Graz, University of Edinburgh, University of Helsinki, Helsinki University Hospital, University of Turku, Vall d'Hebron Hospital Universitari, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, National and Kapodistrian University of Athens, University General Hospital Attikon, University of Manchester, Panagiotis & Aglaia Kyriakou Children's Hospital, Royal Manchester Children's Hospital, University of Crete, Karolinska University Hospital, Sun Yat-sen University, Ghent University Hospital, Karolinska Institutet, University of Amsterdam, Odense University Hospital, Thermo Fisher Scientific (Sweden), Stockholm South General Hospital, Sachs' Children and Youth Hospital, Uppsala University, Transilvania University of Brașov, The University of Sydney, Woolcock Institute of Medical Research, Sydney Local Health District, IDCQ Hospitales y Sanidad, S.L.U., Universidade Federal da Bahia, University of South Florida, Hospital Médica Sur, Finnish Meteorological Institute, Nova Southeastern University, McMaster University, Manisa Celal Bayar University, Université de Versailles Saint-Quentin-en-Yvelines, Humboldt-Universität zu Berlin, Vieillissement et Maladies Chroniques. Approches Epidémiologiques et de santé publique, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité – Universitätsmedizin Berlin
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,790
Funders: AstraZeneca, Sanofi, Teva Pharmaceutical Industries, CSL Behring, Otonomy, Mylan, Allergy Therapeutics, Amsterdam University Medical Centers, Institut National de la Santé et de la Recherche Médicale, Universiteit Leiden, Fundação de Amparo à Pesquisa do Estado de São Paulo, Astellas Pharma, Leids Universitair Medisch Centrum, Universidade de Coimbra, Centre Hospitalier Universitaire Vaudois, Universidade do Porto, Università degli Studi di Salerno, Universidade do Minho, Sorbonne Université, Novartis Pharma, Allergopharma
OpenAlex ID: W3111985162
